160 results
Page 2 of 8
8-K
k0isk
3 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:31am
424B3
zyjp zd7k4tj4m0yfy2
12 Jun 23
Prospectus supplement
5:01pm
8-K
EX-10.1
r7p hjvbjcu
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
424B5
4nvjzaeovsf
21 Apr 23
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.5
pjyv azzdk
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
440ojykb483xiupmdb
10 Nov 22
Prospectus supplement
4:21pm